← Eichor
Study identifier: NCT06964581 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cognitive Rehabilitation of Deficits in Patients With Multiple Sclerosis

Condition: Telerehabilitation · Multiple Sclerosis · Cognitive Disorders  ·  Sponsor: Universita di Verona

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Non-Inferiority Study, Post-Market Clinical Investigation with a Device, Single-Blind Randomized Controlled Trial in a Cohort of Patients Diagnosed with Multiple Sclerosis (MS). The aim of the study is to assess whether a computer-based cognitive treatment delivered via telerehabilitation produces effects from T0 to T1 that are not inferior to those of an in-person treatment on sustained attention in a cohort of patients with MS. The secondary objective is to evaluate the effects of telerehabilitation compared to the same treatment delivered in person on attentional shifting, memory, executive functions, and daily functioning (including cognitive fatigue, quality of life, and mood) in patients with MS.

This description comes directly from the study's public registry record.

Talk to the study team

Valentina Varalta, Doctor  ·  045 8124956  ·  valentina.varalta@univr.it

Always discuss trial participation with your own doctor first.

Locations (1)

Azienda Ospedaliera Universitaria Integrata Verona - UOC di NeuroriabilitazioneVerona, verona, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06964581